VANCOUVER, BC, Jan. 30, 2025 /CNW/ - Power Metals Corp ("Power Metals" or the "Company") (TSXV: PWM) (FRANKFURT: OAA1) (OTCQB: PWRMF) is pleased to announce the appointment of Canaccord Genuity ...

In a report released yesterday, Alex Brooks from Canaccord Genuity reiterated a Buy rating on eEnergy Group (EAAS – Research Report), with a price target of p12.00. The company’s shares opened ...

In a report released today, Matthew Lee from Canaccord Genuity maintained a Buy rating on Sprott (SII – Research Report), with a price target of C$67.00. The company’s shares opened today at ...

As of January 29, 2025, the average one-year price target for Dave is $112.35/share. The forecasts range from a low of $90.90 to a high of $141.75. The average price target represents an increase ...

Canaccord rates Opthea a buy with a $1.25 price target. But the broker thinks it could shoot as high as $3 if a key trial succeeds. But the broker said that with a successful Phase III trial, that ...

For the New York Mets, the franchise has a vacant slot at first base, and luckily for former Bruin JT Schwartz, he could have the opportunity to fill that role. Pete Alonso, the mainstay at first ...

(Sharecast News) - Analysts at Canaccord Genuity raised their target price on home improvement retailer Wickes from 180.0p to 198.0p on Wednesday as a "resilient" Q4 performance drove an upgrade ...

Stephen Schwartz has written 24 shows including Personals (Composer), An Evening with Stephen Schwartz (Composer/Lyricist), Butterflies Are Free (Composer/Lyricist), Godspell (Composer), Mass ...

Barry Schwartz is a technologist and a Contributing Editor to Search Engine Land and a member of the programming team for SMX events. He owns RustyBrick, a NY based web consulting firm.

Canaccord rates Opthea a buy with target of $1.25 – $3 if Phase III trial is successful Opthea’s lead drug shows strong promise in eye disease trials Positive phase III results could lead to big gains ...